US Food and Drug Administration. FDA Approves New Treatment For Crohn's Disease. Rockville, MD: National Press Office; February 27, 2007: Report P07-30.
Sandborn WJ, Hanauer SB, Rutgeerts PJ, et al. Adalimumab for Maintenance Treatment of Crohn's Disease: Results of the CLASSIC II Trial. Gut. 2007 Feb 13 [Epub ahead of print].
Hawk ET, Levin B. Colorectal cancer prevention. J Clin Oncol. 2005;23:378-388.